Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
DiR (DiIC 18 (7)) for Advanced Membrane Labeling & Cell Trac
2026-06-10
DiR (DiIC 18 (7)) offers unmatched sensitivity and longevity for live and fixed cell membrane labeling, neuronal tracing, and extracellular vesicle tracking. Its near-infrared properties and low cytotoxicity make it the gold standard for in vivo imaging and advanced cell tracking workflows.
-
SIRT1/2 Inhibitor IV (Cambinol): Deconstructing Sirtuin-Driv
2026-06-10
Explore the multifaceted utility of SIRT1/2 Inhibitor IV (cambinol) in dissecting sirtuin-regulated pathways, with new insights into astrocyte polarization and tumor suppression. This article leverages cutting-edge research to guide advanced applications and experimental design.
-
Applied Workflows with EZ Cap Cy5 Firefly Luciferase mRNA
2026-06-09
EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables dual-modality tracking—combining direct Cy5 fluorescence with robust bioluminescent reporting—for streamlined transfection optimization and real-time mRNA delivery studies. Its advanced modifications deliver superior translation efficiency and reduced innate immune activation, making it a leading tool for researchers optimizing gene expression assays or developing next-gen mRNA therapeutics.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Precision Tool
2026-06-09
Unlock real-time mRNA tracking and high-efficiency expression with EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP). This dual-reporter system simplifies optimization of delivery vehicles and translation workflows, setting a new standard for advanced gene expression studies.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase in Lip
2026-06-08
CAY10499 empowers researchers to dissect lipid metabolism and immune signaling with unparalleled selectivity, targeting both hormone sensitive lipase (HSL) and monoglyceride lipase (MGL) activities. Its robust performance in both cell-based and biochemical workflows opens new avenues in immunometabolic and atherosclerosis research, offering actionable troubleshooting and protocol optimization strategies.
-
FAST Platform Delivers Food-Grade Nutraceutical Nanoparticle
2026-06-08
This study introduces Facilitated Self-Assembling Technology (FAST) as a surfactant-free, food-grade approach for producing bioavailable nanoparticles of hydrophobic nutraceuticals such as curcumin and resveratrol. The demonstrated improvements in solubility, colloidal stability, and biocompatibility position FAST as a scalable solution for next-generation nutritional supplement development.
-
Enantiomeric Structure in Hydrophobic Polymers Shapes IR-106
2026-06-07
This study investigates how the chiral structure of poly(lactic acid) (PLA) polymers influences the encapsulation and fluorescence properties of IR-1061, a near infrared fluorescent dye, for deep tissue in vivo imaging. The findings advance our understanding of how polymer microenvironments control dye aggregation and stability, providing practical guidance for designing robust NIR-II imaging probes.
-
Ibrexafungerp: Shaping Antifungal Strategies in Translationa
2026-06-06
This article explores the mechanistic and translational significance of Ibrexafungerp (MK 3118), a novel oral antifungal targeting 1,3-β-D-glucan synthase, with a special focus on its efficacy in acidic environments and activity against resistant Candida species. By integrating robust mechanistic insights, recent clinical and in vitro findings, and actionable workflow guidance, we offer strategic direction for researchers seeking to maximize the impact of Ibrexafungerp in both experimental and clinical settings. The discussion advances beyond standard product overviews, critically examining protocol nuances, resistance trends, and future innovation opportunities.
-
IR-1061: Advancing Translational Imaging from Mechanism to M
2026-06-05
This article explores how IR-1061, a near infrared fluorescent dye, is reshaping in vivo imaging for translational researchers. It combines mechanistic insights—grounded in recent nanocatalytic therapy advances—with strategic protocol guidance, benchmarking IR-1061’s performance against traditional dyes, and highlighting how its unique properties expand the frontiers of deep tissue optical imaging.
-
IWR-1-endo: Mechanistic Insights and Innovations in Wnt Path
2026-06-05
Explore how IWR-1-endo, a potent Wnt signaling inhibitor, uniquely advances colorectal cancer research and regenerative biology. This article delivers a deep mechanistic analysis and highlights new insights from single-nucleus profiling to guide innovative experimental design.
-
EV-Transferred ACLY Drives Immunosuppressive Macrophage Fate
2026-06-04
This study uncovers how hepatocellular carcinoma (HCC) cells secrete extracellular vesicles containing ATP-citrate lyase (ACLY), which are preferentially taken up by monocytes and trigger their differentiation into tumor-associated macrophages (TAMs) with a potent immunosuppressive phenotype. Targeting this EV-mediated ACLY transfer represents a promising, mechanistically precise strategy to enhance immunotherapy efficacy in HCC.
-
Cy5 amine (non-sulfonated): Protocols and QC for Biomolecule
2026-06-04
Cy5 amine (non-sulfonated) addresses the need for a bright, stable, amine-reactive fluorescent dye in workflows where water-insolubility is required. It is best suited for protein and polymer labeling in fluorescence microscopy, flow cytometry, and molecular imaging, but is not appropriate for direct aqueous labeling or clinical diagnostic use.
-
KIR2.1 Inhibition Reduces PASMC Proliferation in PH Models
2026-06-03
A recent study uncovers the pivotal role of KIR2.1 potassium channels in regulating pulmonary artery smooth muscle cell (PASMC) proliferation and migration, processes central to pulmonary vascular remodeling in pulmonary hypertension. Pharmacological inhibition of KIR2.1 with ML133 significantly attenuates these cellular events, providing mechanistic insight and a validated experimental strategy for cardiovascular ion channel research.
-
Cy5-UTP: Elevating RNA Labeling for In Vitro Transcription a
2026-06-03
Cy5-UTP (Cyanine 5-uridine triphosphate) unlocks robust, direct RNA probe labeling for advanced fluorescence-based analysis. This guide translates molecular insights and applied workflows into actionable protocols, highlighting troubleshooting and comparative advantages for high-sensitivity RNA detection.
-
Erastin (B1524): A Precision Ferroptosis Inducer Bridging On
2026-06-02
Explore Erastin as a ferroptosis inducer, uniquely analyzed here for its dual role in cancer biology and vascular disease research. This article delivers advanced mechanistic insights and protocol guidance, building on recent breakthroughs in endothelial cell ferroptosis.